Strong first quarter 2023: Sales of Exyte increases by a thi

Significant sales increase by 33,6% to €2.0 billion year-on-yearSubstantial growth of adjusted EBIT and adjusted EBITDA of around 19% to €113 million and €125 million, respectivelyOrder intake

Related Keywords

Singapore , Denmark , Germany , Malaysia , Israel , Gewinn Nur , Prnewswire Exyte Gmbh , Technology Facilities , Technology Services , Biopharma Life Sciences , Corporate Communications , Sales Of The Data Centers , Global Business Units , Next Level , Advanced Technology Facilities , European Chips Act , Science Act , Inflation Reduction , Southeast Asia , Life Sciences , Everest Medicines , Data Centers , Strong , First , Quarter , 023 , Sales , Exyte , Increases , Third , Ear , Billion , Euros ,